The Role of Neoadjuvant Therapy in Sphincter-Saving Surgery for Mid and Distal Rectal Cancer

REFERENCES

• Janjan, N.A.; Khoo, V.S.; Abbruzzese, J.; Pazdur, R.; Dubrow, R.; Cleary, K.R.; Allen, P.K.; Lynch, P.M.; Glober, G.; Wolff, R.; Rich, T.A.; Skibber, J. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience. Int. J. Radiat. Oncol. Biol. Phys. 1999, 44, 1027–1038.
   PubMed Web of Science ®Google Scholar
• Kim, D.W.; Lim, S.B.; Kim, D.Y.; Kim, T.H.; Jung, K.H.; Kim, D.H.; Chang, H.J.; Sohn, D.K.; Hong, C.W.; Choi, H.S.; Jeong, S.Y.; Park, J.G. Pre-operative chemo-radiotherapy improves the sphincter preservation rate in patients with rectal cancer located within 3 cm of the anal verge. Eur. J. Surg. Oncol., 2006, 32, 162–167.
   PubMed Web of Science ®Google Scholar
• Graf, W.; Dahlberg, M.; Osman, M.M.; Holmberg, L.; Pahlman, L.; Glimelius, B. Short-term preoperative radiotherapy results in down-staging of rectal cancer: a study of 1316 patients. Radiother. Oncol., 1997, 43(2), 133–137.
   PubMed Web of Science ®Google Scholar
• Marijnen, C.A.; Nagtegaal, I.D.; Klein Kranenbarg, E.; Hermans, J.; van de Velde, C.J.; Leer, J.W.; van Krieken, J.H. Pathology Review Committee the Cooperative Clinical Investigators. No downstaging after short-term preoperative radiotherapy in rectal cancer patients. J. Clin. Oncol. 2001, 19(7), 1976–1984.
   PubMed Web of Science ®Google Scholar
• Goldberg, P.A.; Nicholls, R.J.; Porter, N.H.; Love, S.; Grimsey, J.E. Long-term results of a randomised trial of short-course low-dose adjuvant pre-operative radiotherapy for rectal cancer: reduction in local treatment failure. Eur. J. Cancer. 1994, 30A(11), 1602–1606.
   PubMed Web of Science ®Google Scholar
• Initial report from a Swedish multicentre study examining the role of preoperative irradiation in the treatment of patients with resectable rectal carcinoma. Swedish Rectal Cancer Trial. Br. J. Surg. 1993, 80(10), 1333–1336.
   Web of Science ®Google Scholar
• Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl. J. Med. 1997, 336(14), 980–987.
   PubMed Web of Science ®Google Scholar
• Folkesson, J.; Birgisson, H.; Pahlman, L.; Cedermark, B.; Glimelius, B.; Gunnarsson, U. Swedish rectal cancer trial: Long lasting benefits from radiotherapy on survival and local recurrence rate. J. Clin. Oncol. 2005, 23(24), 5644–5650.
   PubMed Web of Science ®Google Scholar
• Kapiteijn, E.; Marijnen, C.A.; Nagtegaal, I.D.; Putter, H.; Steup, W.H.; Wiggers, T.; Rutten, H.J.; Pahlman, L.; Glimelius, B.; van Krieken, J.H.; Leer, J.W.; van de Velde, C.J.; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N. Engl. J. Med. 2001, 345(9), 638–646.
   PubMed Web of Science ®Google Scholar
• Marijnen, C.A.M.; Peeters, K.C.M.J.; Putter, H.; Klein Kranenbarg, E.; Stiggelbout, A.M.; Leer, J.W.H.; van de Velde, C.J.H.; for the Cooperative investigators of the TME trial. Long term results, toxicity and quality of life in the TME trial. Radiother. Oncol. 2004, 73 Suppl 1, 127–128 [Abstract].
   Google Scholar
• Peeters, K.C.; Marijnen, C.A.; Nagtegaal, I.D.; Kranenbarg, E.K.; Putter, H.; Wiggers, T.; Rutten, H.; Pahlman, L.; Glimelius, B.; Leer, J.W.; van de Velde, C.J.;Dutch Colorectal Cancer Group. The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann. Surg. 2007, 246(5), 693–701.
   PubMed Web of Science ®Google Scholar
• Bujko, K.; Nowacki, M.P.; Oledzki, J.; Sopylo, R.; Skoczylas, J.; Chwalinski, M. Sphincter preservation after short-term preoperative radiotherapy for low rectal cancer–presentation of own data and a literature review. Acta Oncol. 2001, 40(5), 593–601.
   PubMed Web of Science ®Google Scholar
• Widder, J.; Herbst, F.; Dobrowsky, W.; Schmid, R.; Pokrajac, B.; Jech, B.; Chiari, C.; Stift, A.; Maier, A.; Karner-Hanusch, J.; Teleky, B.; Wrba, F.; Jakesz, R.; Poetter, R. Preoperative short-term radiation therapy (25 Gy, 2.5 Gy twice daily) for primary resectable rectal cancer (phase II). Br. J. Cancer. 2005, 92(7), 1209–1214.
   PubMed Web of Science ®Google Scholar
• Randomised trial of surgery alone versus surgery followed by radiotherapy for mobile cancer of the rectum. Medical Research Council Rectal Cancer Working Party. Lancet. 1996, 348(9042), 1610–1614.
   PubMedGoogle Scholar
• Wagman, R.; Minsky, B.D.; Cohen, A.M.; Guillem, J.G.; Paty, P.P. Sphincter preservation in rectal cancer with preoperative radiation therapy and coloanal anastomosis: long term follow-up. Int. J. Radiat. Oncol. Biol. Phys. 1998, 42(1), 51–57.
   PubMed Web of Science ®Google Scholar
• Rouanet, P.; Saint-Aubert, B.; Lemanski, C.; Senesse, P.; Gourgou, S.; Quenet, F.; Ycholu, M.; Kramar, A.; Dubois, J. Restorative and nonrestorative surgery for low rectal cancer after high-dose radiation: long-term oncologic and functional results. Dis. Colon. Rectum. 2002, 45(3), 305–315.
   PubMed Web of Science ®Google Scholar
• Rengan, R.; Paty, P.; Wong, W.D.; Guillem, J.; Weiser, M.; Temple, L.; Saltz, L.; Minsky, B.D. Distal cT2N0 rectal cancer: is there an alternative to abdominoperineal resection?. J. Clin. Oncol. 2005, 23(22), 4905–49012.
   PubMed Web of Science ®Google Scholar
• Gerard, J.-P.; Chapet, O; Nemoz, C.; Hartweig, J.; Romestaing, P.; Coquard, R.; Barbet, N.; Maingnon, P.; Mahe, M.; Baulieux, J.; Partensky, C.; Papillon, M.; Glehen, O.; Crozet, B.; Grandjean, J.-P.; Adeleine, P. Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: The Lyon R96–02 randomized trial. J. Clin. Oncol. 2004, 22(12), 2404–2409.
   PubMed Web of Science ®Google Scholar
• Grann, A.; Feng, C.; Wong, D.; Saltz, L.; Paty, P.P.; Guillem, J.G.; Cohen, A.M.; Minsky, B.D. Preoperative combined modality therapy for clinically resectable uT3 rectal adenocarcinoma. Int. J. Radiat. Oncol. Biol. Phys. 2001, 49(4), 987–995.
   PubMed Web of Science ®Google Scholar
• Valentini, V.; Coco, C.; Cellini, N.; Picciocchi, A.; Genovesi, D.; Mantini, G.; Barbaro, B.; Cogliandolo, S.; Mattana, C.; Ambesi Impiombato, F.; Tedesco, M.; Cosimelli, M. Preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation. Int. J. Radiat. Oncol. Biol. Phys. 1998, 40(5), 1067–1075.
   PubMed Web of Science ®Google Scholar
• Janjan, N.A.; Crane, C.N.; Feig, B.W.; Cleary, K.; Dubrow, R.; Curley, S.A.; Ellis, L.M.; Vauthey, J.; Lenzi, R.; Lynch, P.; Wolff, R.; Brown, T.; Pazdur, R.; Abbruzzese, J.; Hoff, P.M.; Allen, P.; Brown, B.; Skibber, J. Prospective trial of preoperative concomitant boost radiotherapy with continuous infusion 5-fluorouracil for locally advanced rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 2000, 47(3), 713–718.
   PubMed Web of Science ®Google Scholar
• Sauer, R.; Becker, H.; Hohenberger, W.; Rodel, C.; Wittekind, C.; Fietkau, R.; Martus, P.; Tschmelitsch, J.; Hager, E.; Hess, C.F.; Karstens, J.H.; Liersch, T.; Schmidberger, H.; Raab, R.; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N. Engl. J. Med. 2004, 351(17), 1731–1740.
   PubMed Web of Science ®Google Scholar
• Bujko, K.; Nowacki, M.P.; Nasierowska-Guttmejer, A.; Michalski, W.; Bebenek, M.; Pudelko, M.; Kryj, M.; Oledzki, J.; Szmeja, J.; Sluszniak, J.; Serkies, K.; Kladny, J.; Pamucka, M.; Kukolowicz, P. Sphincter preservation following preoperative radiotherapy for rectal cancer: report of a randomised trial comparing short-term radiotherapy vs. conventionally fractionated radiochemotherapy. Radiother. Oncol. 2004, 72(1), 15–24.
   PubMed Web of Science ®Google Scholar
• Bosset, J.F.; Calais, G.; Mineur, L.; Maingon, P.; Radosevic-Jelic, L.; Daban, A.; Bardet, E.; Beny, A.; Briffaux, A.; Collette, L. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results–EORTC 22921. J. Clin. Oncol. 2005, 23(24), 5620–5627.
   PubMed Web of Science ®Google Scholar
• Bosset, J.F.; Collette, L.; Calais, G.; Mineur, L.; Maingon, P.; Radosevic-Jelic, L.; Daban, A.; Bardet, E.; Beny, A.; Ollier, J.C.; EORTC Radiotherapy Group Trial 22921. Chemotherapy with preoperative radiotherapy in rectal cancer. N. Engl. J. Med. 2006, 355(11), 1114–1123.
   PubMed Web of Science ®Google Scholar
• Guillem, J.G.; Chessin, D.B.; Shia, J.; Moore, H.G.; Mazumdar, M.; Bernard, B.; Paty, P.B.; Saltz, L.; Minsky, B.D.; Weiser, M.R.; Temple, L.K.; Cohen, A.M.; Wong, W.D. Clinical examination following preoperative chemoradiation for rectal cancer is not a reliable surrogate end point. J. Clin. Oncol. 2005, 23(15), 3475–3459.
   PubMed Web of Science ®Google Scholar
• Gerard, J.P.; Chapet, O.; Nemoz, C.; Romestaing, P.; Mornex, F.; Coquard, R.; Barbet, N.; Atlan, D.; Adeleine, P.; Freyer, G. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0–04 phase II trial. J. Clin. Oncol. 2003, 21(6), 1119–1124.
   PubMed Web of Science ®Google Scholar
• Mehta, V.K.; Cho, C.; Ford, J.M.; Jambalos, C.; Poen, J.; Koong, A.; Lin, A.; Bastidas, J.A.; Young, H.; Dunphy, E.P.; Fisher, G. Phase II trial of preoperative 3D conformal radiotherapy, protracted venous infusion 5-fluorouracil, and weekly CPT-11, followed by surgery for ultrasound-staged T3 rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 2003, 55(1), 132–137.
   PubMed Web of Science ®Google Scholar
• Rodel, C.; Grabenbauer, G.G.; Papadopoulos, T.; Hohenberger, W.; Schmoll, H.J.; Sauer, R. Phase I/II trial of capecitabine, oxaliplatin, and radiation for rectal cancer. J. Clin. Oncol. 2003, 21(16), 3098–3104.
   PubMed Web of Science ®Google Scholar
• Gambacorta, M.A.; Valentini, V.; Coco, C.; Morganti, A.G.; Smaniotto, D.; Micciche, F.; Mantini, G.; Barbaro, B.; Garcia-Vargas, J.E.; Magistrelli, P.; Picciocchi, A.; Cellini, N. Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II III resectable rectal cancer: Phase I and II studies. Int. J. Radiat. Oncol. Biol. Phys. 2004, 60(1), 139–148.
   PubMed Web of Science ®Google Scholar
• Gambacorta, M.A.; Valentini, V.; Morganti, A.G.; Mantini, G.; Micciche, F.; Ratto, C.; Di Miceli, D.; Rotondi, F.; Alfieri, S.; Doglietto, G.B.; Vargas, J.G.; De Paoli, A.; Rossi, C.; Cellini, N. Chemoradiation with raltitrexed (Tomudex) in preoperative treatment of stage II III resectable rectal cancer: a phase II study. Int. J. Radiat. Oncol. Biol. Phys. 2004, 60(1), 130–138.
   PubMed Web of Science ®Google Scholar
• Aschele, C.; Friso, M.L.; Pucciarelli, S.; Lonardi, S.; Sartor, L.; Fabris, G.; Urso, E.D.; Del Bianco, P.; Sotti, G.; Lise, M.; Monfardini, S. A phase I II study of weekly oxaliplatin, 5-fluorouracil continuous infusion and preoperative radiotherapy in locally advanced rectal cancer. Ann. Oncol. 2005, 16(7), 1140–1146.
   PubMed Web of Science ®Google Scholar
• Valentini, V.; Coco, C.; Cellini, N.; Picciocchi, A.; Fares, M.C.; Rosetto, M.E.; Mantini, G.; Morganti, A.G.; Barbaro, B.; Cogliandolo, S.; Nuzzo, G.; Tedesco, M.; Ambesi Impiombato, F.; Cosimelli, M.; Rotman, M. Ten years of preoperative chemoradiation for extraperitoneal T3 rectal cancer: acute toxicity, tumor response, and sphincter preservation in three consecutive studies. Int. J. Radiat. Oncol. Biol. Phys. 2001, 51(12), 371–383.
   PubMedGoogle Scholar
• Valentini, V.; Coco, C.; Minsky, B.D.; Gambacorta, M.A.; Cosimelli, M.; Bellavita, R.; Morganti, A.G.; La Torre, G.; Trodella, L.; Genovesi, D.; Portaluri, M.; Maurizi-Enrici, R.; Barbera, F.; Maranzano, E.; Lupattelli, M. Randomized, multicenter, phase IIb study of preoperative chemoradiotherapy in T3 mid-distal rectal cancer: raltitrexed +oxaliplatin + radiotherapy versus cisplatin + 5-fluorouracil + radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 2008, 70(2), 403–412.
   PubMed Web of Science ®Google Scholar
• Chung, K.Y.; Minsky, B.; Schrag, D.; O’Reilly, E.; D’Adamo, D.; Hollywood, E.; Quinones, L.; Saltz, L. Phase I trial of preoperative cetuximab with continous infusion 5-fluorouracil and pelvic radiation in patients with local-regionally advanced rectal cancer. ASCO Annual Meeting Proceedings. 2006, Vol. 24, No. 18S, 161S, Abstract: 3560.
   Google Scholar
• Machiels, J.P.; Sempoux, C.; Scalliet, P.; Coche, J.C.; Humblet, Y.; Van Cutsem, E.; Kerger, J.; Canon, J.L.; Peeters, M.; Aydin, S.; Laurent, S.; Kartheuser, A.; Coster, B.; Roels, S.; Daisne, J.F.; Honhon, B.; Duck, L.; Kirkove, C.; Bonny, M.A.; Haustermans, K. Phase I/II study of preoperative cetuximab, capecitabine, and external beam radiotherapy in patients with rectal cancer. Ann. Oncol. 2007, 18(4), 738–744.
   PubMed Web of Science ®Google Scholar
• Willett, C.G.; Boucher, Y.; Duda, D.G.; di Tomaso, E.; Munn, L.L.; Tong, R.T.; Kozin, S.V.; Petit, L.; Jain, R.K.; Chung, D.C.; Sahani, D.V.; Kalva, S.P.; Cohen, K.S.; Scadden, D.T.; Fischman, A.J.; Clark, J.W.; Ryan, D.P.; Zhu, A.X.; Blaszkowsky, L.S.; Shellito, P.C.; Mino-Kenudson, M.; Lauwers, G.Y. Surrogate markers for antiangiogenic therapy and dose-limiting toxicities for bevacizumab with radiation and chemotherapy: continued experience of a phase I trial in rectal cancer patients. J. Clin. Oncol. 2005, 23(31), 8136–8139.
   PubMed Web of Science ®Google Scholar
• Chau, I.; Brown, G.; Cunningham, D.; Tait, D.; Wotherspoon, A.; Norman, A.R.; Tebbutt, N.; Hill, M.; Ross, P.J.; Massey, A.; Oates, J. Neoadjuvant capecitabine and oxaliplatin followed by synchronous chemoradiation and total mesorectal excision in magnetic resonance imaging-defined poor-risk rectal cancer. J. Clin. Oncol. 2006, 24(4), 668–674.
   PubMed Web of Science ®Google Scholar
• Zmora, O.; Dasilva, G.M.; Gurland, B.; Pfeffer, R.; Koller, M.; Nogueras, J.J.; Wexner, S.D. Does rectal wall tumor eradication with preoperative chemoradiation permit a change in the operative strategy?. Dis. Colon. Rectum. 2004, 47(10), 1607–1612.
   PubMed Web of Science ®Google Scholar
• Ruo, L.; Tickoo, S.; Klimstra, D.S.; Minsky, B.D.; Saltz, L.; Mazumdar, M.; Paty, P.B.; Wong, W.D.; Larson, S.M.; Cohen, A.M.; Guillem, J.G. Long-term prognostic significance of extent of rectal cancer response to preoperative radiation and chemotherapy. Ann. Surg. 2002, 236(1), 75–81.
   PubMed Web of Science ®Google Scholar
• Pucciarelli, S.; Toppan, P.; Friso, M.L.; Russo, V.; Pasetto, L.; Urso, E.; Marino, F.; Ambrosi, A.; Lise, M. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome. Dis. Colon. Rectum. 2004, 47(11), 1798–1807.
   PubMed Web of Science ®Google Scholar
• Onaitis, M.W.; Noone, R.B.; Fields, R.; Hurwitz, H.; Morse, M.; Jowell, P.; McGrath, K.; Lee, C.; Anscher, M.S.; Clary, B.; Mantyh, C.; Pappas, T.N.; Ludwig, K.; Seigler, H.F.; Tyler, D.S. Complete response to neoadjuvant chemoradiation for rectal cancer does not influence survival. Ann. Surg. Oncol. 2001, 8(10), 801–806.
   PubMed Web of Science ®Google Scholar
• Guillem, J.G.; Chessin, D.B.; Cohen, A.M.; Shia, J.; Mazumdar, M.; Enker, W.; Paty, P.B.; Weiser, M.R.; Klimstra, D.; Saltz, L.; Minsky, B.D.; Wong, W.D. Long-term oncologic outcome following preoperative combined modality therapy and total mesorectal excision of locally advanced rectal cancer. Ann. Surg. 2005, 241(5), 829–838.
   PubMed Web of Science ®Google Scholar
• Bouzourene, H.; Bosman, F.T.; Seelentag, W.; Matter, M.; Coucke, P. Importance of tumor regression assessment in predicting the outcome in patients with locally advanced rectal carcinoma who are treated with preoperative radiotherapy. Cancer. 2002, 94(4), 1121–1130.
   PubMed Web of Science ®Google Scholar
• Vecchio, F.M.; Valentini, V.; Minsky, B.D.; Padula, G.D.; Venkatraman, E.S.; Balducci, M.; Micciche, F.; Ricci, R.; Morganti, A.G.; Gambacorta, M.A.; Maurizi, F.; Coco, C. The relationship of pathologic tumor regression grade (TRG) and outcomes after preoperative therapy in rectal cancer. Int. J. Radiat. Oncol. Biol. Phys. 2005, 62(3), 752–760.
   PubMed Web of Science ®Google Scholar
• Gavioli, M.; Luppi, G.; Losi, L.; Bertolini, F.; Santantonio, M.; Falchi, A.M.; D’Amico, R.; Conte, P.F.; Natalini, G. Incidence and clinical impact of sterilized disease and minimal residual disease after preoperative radiochemotherapy for rectal cancer. Dis. Colon. Rectum. 2005, 48(10), 1851–1857.
   PubMed Web of Science ®Google Scholar
• Rodel, C.; Martus, P.; Papadoupolos, T.; Fuzesi, L.; Klimpfinger, M.; Fietkau, R.; Liersch, T.; Hohenberger, W.; Raab, R.; Sauer, R.; Wittekind, C. Prognostic Significance of Tumor Regression After Preoperative Chemoradiotherapy for Rectal Cancer. J. Clin. Oncol. 2005, 23(34), 8688–8696.
   PubMed Web of Science ®Google Scholar
• Stipa, F.; Chessin, D.B.; Shia, J.; Paty, P.B.; Weiser, M.; Temple, L.K.F.; Minsky, B.D.; Wong, W.D.; Guillem, J.G. A pathologic complete response of rectal cancer to preoperative combined-modality therapy results in improved oncological outcome compared with those who achieve no downstaging on the basis of preoperative endorectal ultrasonography. Ann. Surg. Oncol. 2006, 13(8), 1047–1053.
   PubMed Web of Science ®Google Scholar
• Rosenberg, R.; Nekarda, H.; Zimmermann, F.; Becker, K.; Lordick, F.; Hofler, H.; Molls, M.; Siewert, J.R. Histopathological response after preoperative radiochemotherapy in rectal carcinoma is associated with improved overall survival. J. Surg. Oncol. 2008, 97(1), 8–13.
   PubMed Web of Science ®Google Scholar
• Habr-Gama, A.; Perez, R.O.; Nadalin, W.; Sabbaga, J.; Ribeiro, U. Jr.; Silva e Sousa, A.H. Jr.; Campos, F.G.; Kiss, D.R.; Gama-Rodrigues, J. Operative versus nonoperative treatment for stage 0 distal rectal cancer following chemoradiation therapy: long-term results. Ann. Surg. 2004, 240(4), 711–718.
   PubMed Web of Science ®Google Scholar
• Schaffzin, D.M.; Wong, W.D. Endorectal ultrasound in the preoperative evaluation of rectal cancer. Clin. Colorectal. Cancer. 2004, 4(2), 124–132. Review.
   PubMedGoogle Scholar
• Vanagunas, A.; Lin, D.E.; Stryker, S.J. Accuracy of endoscopic ultrasound for restaging rectal cancer following neoadjuvant chemoradiation therapy. Am. J. Gastroenterol. 2004, 38(1), 35–40.
   Google Scholar
• Rau, B.; Hunerbein, M.; Barth, C.; Wust, P.; Haensch, W.; Riess, H.; Felix, R.; Schlag, P.M. Accuracy of endorectal ultrasound after preoperative radiochemotherapy in locally advanced rectal cancer. Surg. Endosc. 1999, 13(10), 980–984.
   PubMed Web of Science ®Google Scholar
• Kwok, H.; Bissett, I.P.; Hill, G.L. Preoperative staging of rectal cancer. Int. J. Colorectal. Dis. 2000, 15(1), 9–20. Review.
   PubMed Web of Science ®Google Scholar
• Kuo, L.J.; Chern, M.C.; Tsou, M.H.; Liu, M.C.; Jian, J.J.; Chen, C.M.; Chung, Y.L.; Fang, W.T. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradiation therapy. Dis. Colon. Rectum. 2005, 48(1), 23–28.
   PubMed Web of Science ®Google Scholar
• Chen, C.C.; Lee, R.C.; Lin, J.K.; Wang, L.W.; Yang, S.H. How accurate is magnetic resonance imaging in restaging rectal cancer in patients receiving preoperative combined chemoradiotherapy?. Dis. Colon. Rectum. 2005, 48(4), 722–728.
   PubMed Web of Science ®Google Scholar
• Denecke, T.; Rau, B.; Hoffmann, K.-T.; Hildebrandt, B.; Ruf, J.; Gutberlet, M.; Huenerbein, M.; Felix, R.; Wust, P.; Amthauer, H. Comparison of CT, MRI and FDG-PET in response prediction of patients with locally advanced rectal cancer after multimodal preoperative therapy: Is there a benefit in using functional imaging?. Eur. Radiol. 2005, 15(8), 1658–1666.
   PubMed Web of Science ®Google Scholar
• Guillem, J.G.; Moore, H.G.; Akhurst, T.; Klimstra, D.S.; Ruo, L.; Mazumdar, M.; Minsky, B.D.; Saltz, L.; Wong, W.D.; Larson, S. Sequential preoperative fluorodeoxyglucose-positron emission tomography assessment of response to preoperative chemoradiation: A means for determining longterm outcomes of rectal cancer. J. Am. Coll. Surg. 2004, 199(1), 1–7.
   PubMed Web of Science ®Google Scholar
• Calvo, F.A.; Domper, M.; Matute, R.; Martinez-Lazaro, R.; Arranz, J.A.; Desco, M.; Alvarez, E.; Carreras, J.L. 18F-FDG positron emission tomography staging and restaging in rectal cancer treated with preoperative chemoradiation. Int. J. Radiat. Oncol. Biol. Phys. 2004, 58(2), 528–535.
   PubMed Web of Science ®Google Scholar
• Amthauer, H.; Denecke, T.; Rau, B.; Hildebrandt, B.; Huenerbein, M.; Ruf, J.; Schneider, U.; Gutberlet, M.; Schlag, P.M.; Felix, R.; Wust, P. Response prediction by FDG-PET after neoadjuvant radiochemotherapy and combined regional hyperthermia of rectal cancer: Correlation with endorectal ultrasound and histopathology. Eur. J. Nucl. Med. 2004, 31(6), 811–819.
   Google Scholar
• Capirci, C.; Rampin, L.; Erba, P.A.; Galeotti, F.; Crepaldi, G.; Banti, E.; Gava, M.; Fanti, S.; Mariani, G.; Muzzio, P.C.; Rubello, D. Sequential FDG-PET/CT reliably predicts response of locally advanced rectal cancer to neo-adjuvant chemo-radiation therapy. Eur. J. Nucl. Med. Mol. Imaging. 2007, 34(10), 1583–1593.
   PubMed Web of Science ®Google Scholar
• Avril, N.; Sassen, S.; Schmalfeldt, B.; Naehrig, J.; Rutke, S.; Weber, W.A.; Werner, M.; Graeff, H.; Schwaiger, M.; Kuhn, W. Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer. J. Clin. Oncol. 2005, 23(30), 7445–7453.
   PubMed Web of Science ®Google Scholar
• Dose Schwarz, J.; Bader, M.; Jenicke, L.; Hemminger, G.; Janicke, F.; Avril, N. Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET. J. Nucl. Med. 2005, 46(7), 1144–1150.
   PubMed Web of Science ®Google Scholar
• Williams, N.S.; Dixon, M.F.; Johnston, D. Reappraisal of the 5 centimeter rule of distal excision for carcinoma of the rectum: a study of distal intramural spread and of patients’ survival. Br. J. Surg. 1983, 70(3), 150–154.
   PubMed Web of Science ®Google Scholar
• Madsen, P.M.; Christiansen, J. Distal intramural spread of rectal carcinomas. Dis. Colon. Rectum. 1986, 29(4), 279–282.
   PubMed Web of Science ®Google Scholar
• Vernava, A.M. 3rd; Moran, M.; Rothenberger, D.A.; Wong, W.D. A prospective evaluation of distal margins in carcinoma of the rectum. Surg. Gynecol. Obstet. 1992, 175(4), 333–336.
   PubMedGoogle Scholar
• Shirouzu, K.; Isomoto, H.; Kakegawa, T. Distal spread of rectal cancer and optimal distal margin of resection for sphincter-preserving surgery. Cancer. 1995, 76(3). 388–392.
   PubMed Web of Science ®Google Scholar
• Andreola, S.; Leo, E.; Belli, F.; Bonfanti, G.; Sirizzotti, G.; Greco, P.; Valvo, F.; Tomasic, G.; Gallino, G.F. Adenocarcinoma of the lower third of the rectum surgically treated with a <10-MM distal clearance: preliminary results in 35 N0 patients. Ann. Surg. Oncol. 2001, 8(7), 611–615.
   PubMed Web of Science ®Google Scholar
• Kuvshinoff, B.; Maghfoor, I.; Miedema, B.; Bryer, M.; Westgate, S.; Wilkes, J.; Ota, D. Distal margin requirements after preoperative chemoradiotherapy for distal rectal carcinomas: are < or = 1 cm distal margins sufficient?. Ann. Surg. Oncol. 2001, 8(2), 163–169.
   PubMed Web of Science ®Google Scholar
• Moore, H.G.; Riedel, E.; Minsky, B.D.; Saltz, L.; Paty, P.; Wong, D.; Cohen, A.M.; Guillem, J.G. Adequacy of 1-cm distal margin after restorative rectal cancer resection with sharp mesorectal excision and preoperative combined-modality therapy. Ann. Surg. Oncol. 2003, 10(1), 80–85.
   PubMed Web of Science ®Google Scholar
• Guillem, J.G.; Chessin, D.B.; Shia, J.; Suriawinata, A.; Riedel, E.; Moore, H.G.; Minsky, B.D.; Wong, W.D. A prospective pathologic analysis using whole mount sections of rectal cancer following preoperative combined modality therapy: Implications for sphincter preservation. Ann. Surg. 2007, 245, 1, 88–93.
   PubMed Web of Science ®Google Scholar
• Luna-Perez, P.; Bustos-Cholico, E.; Alvarado, I.; Maffuz, A.; Rodriguez-Ramirez, S.; Gutierrez de la Barrera, M.; Labastida, S. Prognostic significance of circumferential margin involvement in rectal adenocarcinoma treated with preoperative chemoradiotherapy and low anterior resection. J. Surg. Oncol. 2005, 90(1), 20–25.
   PubMed Web of Science ®Google Scholar
• Rullier, E.; Laurent, C.; Bretagnol, F.; Rullier, A.; Vendrely, V.; Zerbib, F. Sphincter-saving resection for all rectal carcinomas. The end of the 2-cm distal rule. Ann. Surg. 2005, 241(3), 465–469.
   PubMed Web of Science ®Google Scholar